La cadena de opciones muestra datos clave de las opciones de acciones de Spero Therapeutics a varios precios de ejercicio y fechas de vencimiento. Los operadores utilizan esta información para analizar posibles operaciones y evaluar el sentimiento del mercado para Spero Therapeutics..

Spero Therapeutics (NASDAQ:SPRO) Bolsa, Cadena de Opciones

SPERO THERAPEUTICS INC

Spero Therapeutics

Spero Therapeutics Inc is a clinical-stage biopharmaceutical firm. It focuses on identifying, developing, and commercializing novel treatments for MDR (Multi-drug-resistant) bacterial infections and rare diseases. The company's product candidate, tebipenem pivoxil hydrobromide or tebipenem HBr, is designed to be an oral carbapenem-class antibiotic for use in adults to treat MDR Gram-negative infections. It is also developing SPR720, a novel oral antibiotic designed for the treatment of a rare, orphan disease caused by pulmonary non-tuberculous mycobacterial infections, or NTM disease. Besides, it is also focused on SPR206, a next-generation polymyxin investigational product candidate being developed as an IV-administered medicine to treat MDR Gram-negative infections in the hospital.

Spero Therapeutics Inc

Sprott Physical Silver Trust

Sprott Physical Gold Trust

Sprouts Farmers Market, Inc. - Common Stock

Sprouts Farmers Market Inc

Sprott Physical Gold and Silver Trust Units

Sprott Physical Gold and Silver Trust

Sprott Physical Platinum and Palladium Trust

Sprott Physical Platinum & Palladium Tr

Sprout Social, Inc - Class A Common Stock

Sprout Social Inc

Sprott Uranium Miners ETF

Sprott Junior Uranium Miners ETF

SPROTT PHYSICL URNIUM UT by Sprott Physical Uranium Trust

Sprott Physical Uranium Trust

Sprott Silver Miners & Physical Silver ETF

Sprott Critical Materials ETF

Sprott Nickel Miners ETF

Sprott Inc

Sprott Gold Miners ETF

Sprott Active Gold & Silver Miners ETF

Sprott Lithium Miners ETF

Sprott Junior Gold Miners ETF

Sprott Active Metals & Miners ETF

Sprott Copper Miners ETF

Sprott Junior Copper Miners ETF

Sprott Focus Trust, Inc. - Closed End Fund

Sprott Focus Trust Inc

SPROTT PHYSICAL CPPER UTS by Sprott Physical Copper Trust

Sprout AI Inc

SPROUT TINY HOMES by Sprout Tiny Homes, Inc.

Sprout Tiny Homes Inc

Sproutly Canada Inc

Earnings

Press Releases

Spero Therapeutics Announces Fourth Quarter and Full Year 2024 Operating Results and Provides a Business Update

News

Management

Spero Therapeutics Appoints Esther Rajavelu as President and Chief Executive Officer

Spero Therapeutics to Report First Quarter 2025 Financial Results and Provide Business Update on Tuesday, May 13, 2025

Spero Therapeutics Announces First Quarter 2025 Operating Results and Provides a Business Update

Spero Therapeutics and GSK Announce PIVOT-PO Phase 3 Study for Tebipenem HBr Stopped Early for Efficacy Following Review by Independent Data Monitoring Committee

Small-Cap Movers Under $1: HIT, SPRO, SGN, PRSO, SGBX Drive Momentum Across AI, Biotech, Crypto, Software, Etc.

Spero Therapeutics to Report Second Quarter 2025 Financial Results and Provide Business Update on Tuesday, August 12, 2025

Spero Therapeutics Announces Second Quarter 2025 Operating Results and Provides a Business Update

Spero Therapeutics Announces Presentations on Tebipenem Hbr at IDWeek

PIVOT-PO Phase 3 Data Show Tebipenem HBr's Potential as the First Oral Carbapenem Antibiotic for Patients with Complicated Urinary Tract Infections (cUTIs)

PRSO

SGBX

SPRO

Acumen Pharmaceuticals, Inc. - Common Stock

Acumen Pharmaceuticals

Adicet Bio

Agenus

Anika Therapeutics

Anixa Biosciences

Artiva Biotherapeutics, Inc. - Common Stock

Artiva Biotherapeutics

Atossa Therapeutics

Climb Bio

Coya Therapeutics

Greenwich LifeSciences, Inc. - Common stock

Greenwich LifeSciences

Inhibikase Therapeutics, Inc. - Common Stock

Inhibikase Therapeutics

Inovio Pharmaceuticals, Inc. - Common Stock

Inovio Pharmaceuticals

Opus Genetics

MDxHealth

Macrogenics

Molecular Partners AG - American Depositary Shares

Molecular Partners

Oncolytics Biotech

Sera Prognostics, Inc. - Class A Common Stock

Sera Prognostics

Surrozen

TScan Therapeutics

Instil Bio

Tevogen Bio Holdings

Vistagen Therapeutics, Inc. - Common Stock

Vistagen Therapeutics

Whitehawk Therapeutics, Inc. - Common Stock

Whitehawk Therapeutics

Zentalis Pharmaceuticals, Inc. - common stock

Comments

Spero Therapeutics

Spero Therapeutics (SPRO) Opciones

Spero Therapeutics (NASDAQ:SPRO) Bolsa, Cadena de Opciones

Noticias

SOCIO/CONTRIBUIDOR

BENZINGA GLOBAL